"Enhanced Gene Editing: Virus-Like Delivery System Restores Vision in Mice"
Researchers led by gene editing pioneer David Liu have developed virus-like particles (eVLPs) to deliver all the necessary components for prime editing, demonstrating its use in mice to deliver a gene editing therapy that partially restores vision. The study, published in Nature Biotechnology, showcases a non-infectious delivery system for prime editing, offering potential for therapeutic applications.